Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Sep 8, 2026
- Accession no.
- 0001106578-26-000136
- Filed
- Sep 8, 2026, 4:31 PM ET
- Trade date
- Sep 4, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.65M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Common Stock | MOption exerciseAcquired | +9,500 | $117.76 | +$1,118,720 | 333,943 | Indirect | |
| Sep 4, 2026 | Common Stock | SSaleDisposed | −40 | $485.85F3 | −$19,433.82 | 333,903 | Indirect | |
| Sep 4, 2026 | Common Stock | SSaleDisposed | −223 | $486.88F4 | −$108,573.86 | 333,680 | Indirect | |
| Sep 4, 2026 | Common Stock | SSaleDisposed | −2,818 | $488.08F5 | −$1,375,398.17 | 330,862 | Indirect | |
| Sep 4, 2026 | Common Stock | SSaleDisposed | −3,425 | $489.12F6 | −$1,675,248.33 | 327,437 | Indirect | |
| Sep 4, 2026 | Common Stock | SSaleDisposed | −1,514 | $490.01F7 | −$741,873.93 | 325,923 | Indirect | |
| Sep 4, 2026 | Common Stock | SSaleDisposed | −1,160 | $490.94F8 | −$569,484.72 | 324,763 | Indirect | |
| Sep 4, 2026 | Common Stock | SSaleDisposed | −320 | $491.69F9 | −$157,341.6 | 324,443 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 489,910 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $485.41 to $486.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $486.43 to $487.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $487.51 to $488.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $488.54 to $489.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $489.57 to $490.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $490.57 to $491.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $491.65 to $491.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.